Track topics on Twitter Track topics that are important to you
Here are the most relevant search results for "Globes" found in our extensive news archives from over 250 global news sources.
In addition to our news stories we have dozens of PubMed Articles about Globes for you to read. Along with our medical data and news we also list Globes Clinical Trials, which are updated daily. BioPortfolio also has a large database of Globes Companies for you to search.
The study will evaluate the safety, usability, and subject compliance of the C-Scan system.
The pharmaceutical giant has bought land in Ramat Hahayal and will be moving its head office there from Petah Tikva in mid-2020.
BiomX's XMarker microbiome-based biomarker discovery platform will be used to stratify responders and non-responders to inflammatory bowel disease therapeutics.
The companies will register Cannbit for overseas trading and dual-listing of Namaste on the TASE.
HeraMED has developed a small monitor for home use that tracks fetal heartbeats.
Engineering for All has become the 8th portfolio company in the eHealth Ventures technological incubator.
The company is developing a minimally invasive catheter-based approach to treat acute decompensated heart failure.
Entera will use its proprietary drug delivery platform to develop oral formulations for one preclinical large molecule program in inflammatory diseases and other serious illnesses that Amgen has selected.
Teva is reportedly being investigated in the US for allegedly forming a cartel and fixing prices for 300 drugs.
GIBF is investing $7 million in the joint venture with Nazareth-based Alpha Omega, which produces devices for deep brain stimulation surgery.
"The Washington Post" reports that prosecutors are investigating "the largest cartel in the history of the US." Teva: The allegations are devoid of facts.
The Israeli company will use the funds for the commercial launch of H.pylori drug TALICIA and two phase III clinical trials.
Omar Ishrak was a guest of honor at the International Conference for Innovations in Cardiovascular Systems.
Tikun Olam will be short of cannabis until its Kfar Yehoshua farms is approved.
Even if the bill passes until law, its implementation will still depend on Prime Minister Benjamin Netanyahu giving the green light.
Omar Ishrak heads a delegation of senior executives who will become acquainted with Medtronics recent acquisitions - Mazor Robotics, Nutrino and Visionsense.
The program will give companies easy access to hospital resources and technological assistance.
The companies have not announced a date for launching their version of the non-Hodgkin's Disease lymphoma treastment.
Billionaire Gary Fegel, an associate of InterCure chairperson and former Prime Minister Ehud Barak, led the $5 million round.
The treatment for life-threatening allergies has been the flagship branded drug of Mylan, Teva's generic pharmaceutical rival.
Following cancelation of the deal for merging Brown Hotels into it, stock exchange shell Herodium has found an alternative.
Merchavia is investing $400,000 for 20% of an Israeli company, which has developed unique technology for inhaling precise doses of cannabis.
Disinvestment by Teva from Israeli drug development companies and thousands of employees laid off have had advantages for Israel's pharma industry.
The Tel Aviv-based nutrition-relateddata services, analytics,and technologies company will be integrated into Medtronic's Diabetes Group.
Private equity fund XIO acquired the Yokneam-based aesthetic medical device company in 2015 for $520 million.